H3 inverse agonist clinical candidate

Lead Generation Paved the Way for the Discovery of a Novel H3 Inverse Agonist Clinical Candidate... 

In this chapter, we will describe our strategies and paths followed, starting from the identification of early hits, to identify novel drug-like H3 inverse agonists lead series, devoid of known class issues and offering potential for differentiation, ultimately optimized into a clinical candidate. 

---